Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-12-02T19:40:27.578Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiology of Multidrug-Resistant Bacteria in Patients With Long Hospital Stays

Published online by Cambridge University Press:  02 January 2015

Cagri Buke ,
Laurence Armand-Lefevre ,
Isabelle Lolom ,
Waafa Guerinot ,
Claude Deblangy ,
Raymond Ruimy ,
Antoine Andremont  and
Jean-Christophe Lucet
Cagri Buke
Affiliation:
Infection Control Unit, Bichat-Claude Bernard Teaching Hospital, Assistance Publique—Hôpitaux de Paris, andParis VII Denis Diderot University, Paris, France Ege University Faculty of Medicine, Izmir, Turkey
Laurence Armand-Lefevre
Affiliation:
Bacteriology Laboratory, Bichat-Claude Bernard Teaching Hospital, Assistance Publique—Hôpitaux de Paris, andParis VII Denis Diderot University, Paris, France
Isabelle Lolom
Affiliation:
Infection Control Unit, Bichat-Claude Bernard Teaching Hospital, Assistance Publique—Hôpitaux de Paris, andParis VII Denis Diderot University, Paris, France
Waafa Guerinot
Affiliation:
Infection Control Unit, Bichat-Claude Bernard Teaching Hospital, Assistance Publique—Hôpitaux de Paris, andParis VII Denis Diderot University, Paris, France
Claude Deblangy
Affiliation:
Infection Control Unit, Bichat-Claude Bernard Teaching Hospital, Assistance Publique—Hôpitaux de Paris, andParis VII Denis Diderot University, Paris, France
Raymond Ruimy
Affiliation:
Bacteriology Laboratory, Bichat-Claude Bernard Teaching Hospital, Assistance Publique—Hôpitaux de Paris, andParis VII Denis Diderot University, Paris, France
Antoine Andremont
Affiliation:
Bacteriology Laboratory, Bichat-Claude Bernard Teaching Hospital, Assistance Publique—Hôpitaux de Paris, andParis VII Denis Diderot University, Paris, France
Jean-Christophe Lucet*
Affiliation:
Infection Control Unit, Bichat-Claude Bernard Teaching Hospital, Assistance Publique—Hôpitaux de Paris, andParis VII Denis Diderot University, Paris, France
*
Unité d'Hygiène et de Lutte contre l'lnfection Nosocomiale, GH Bichat-Claude Bernard, 75877 Paris Cedex 18, France ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To determine rates of colonization with multidrug-resistant (MDR) bacteria (ie, methicillin-resistant Staphylococcus aureus [MRSA], vancomycin-resistant Enterococcus [VRE], extended-spectrum β-lactamase [ESBL]-producing Enterobacteriaceae, and Acinetobacter baumannii) after prolonged hospitalization and to assess the yield of surveillance cultures and variables associated with colonization with MDR bacteria.

Design.

Prospective observational cohort study conducted from February 6 to May 26, 2006.

Methods.

All patients who spent more than 30 days in our university hospital (Paris, France) were included. Rectal and nasal swab samples obtained during day 30 screening were examined for MRSA, VRE, ESBL-producing Enterobacteriaceae, and A. baumannii.

Results.

Of 470 eligible patients, 439 had surveillance culture samples available for analysis, including 51 patients (11.6%) with a history of colonization or infection due to 1 or more types of MDR bacteria (MRSA, recovered from 35 patients; ESBL-producing Enterobacteriaceae, from 16 patients; A. baumannii, from 6 patients; and VRE, from 0 patients) and 37 patients (9.5% of the 388 patients not known to have any of the 4 MDR bacteria before day 30 screening) newly identified as colonized by 1 or more MDR bacteria (MRSA, recovered from 20 patients; ESBL-producing Enterobacteriaceae, from 16 patients; A. baumannii, from 1 patient; and VRE, from 0 patients). A total of 87 (19.8%) of 439 patients were identified as colonized or infected with MDR bacteria at day 30. Factors that differed between patients with and without MRSA colonization included age, McCabe score, comorbidity score, receipt of surgery, and receipt of fluoroquinolone treatment. Patients with ESBL-producing Enterobacteriaceae colonization were younger than patients with MRSA colonization.

Conclusions.

Differences in the variables associated with MRSA colonization and ESBL-producing Enterobacteriaceae colonization suggest differences in the epidemiology of these 2 organisms. Day 30 screening resulted in a 72.5% increase in the number of patients identified as colonized with at least 1 type of MDR bacteria.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 11 , November 2007 , pp. 1255 - 1260
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003;31:481–498.CrossRefGoogle Scholar
2.Urban, C, Segal-Maurer, S, Rahal, JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003;36:1268–1274.Google Scholar
3.Paterson, DL, Bonomo, RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657–686.Google Scholar
4.Rahal, JJ, Urban, C, Segal-Maurer, S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis 2002;34:499–503.CrossRefGoogle ScholarPubMed
5.Warren, DK, Nitin, A, Hill, C, Fraser, VJ, Kollef, MH. Occurrence of co-colonization or coinfection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2004;25:99–104.Google Scholar
6.Furuno, JP, McGregor, JC, Harris, AD, et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 2006;166:580–585.CrossRefGoogle ScholarPubMed
7.Furuno, JP, Perencevich, EN, Johnson, JA, et al. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization. Emerg Infect Dis 2005;11:1539–1544.Google Scholar
8.Harris, AD, Nemoy, L, Johnson, JA, et al. Cocarriage rates of vancomycin-resistant Enterococcus and extended-spectrum β-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program. Infect Control Hosp Epidemiol 2004;25:105–108.Google Scholar
9.Safdar, N, Maki, DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136:834–844.Google Scholar
10.Muto, CA, Jernigan, JA, Ostrowsky, BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362–386.CrossRefGoogle ScholarPubMed
11.Harbarth, S, Sax, H, Fankhauser-Rodriguez, C, Schrenzel, J, Agostinho, A, Pittet, D. Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med 2006;119:275e15–275e23.Google Scholar
12.Fishbain, JT, Lee, JC, Nguyen, HD, et al. Nosocomial transmission of methicillin-resistant Staphylococcus aureus: a blinded study to establish baseline acquisition rates. Infect Control Hosp Epidemiol 2003;24:415–421.Google Scholar
13.Lucet, JC, Paoletti, X, Lolom, I, et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005;31:1051–1057.CrossRefGoogle ScholarPubMed
14.Huang, SS, Yokoe, DS, Hinrichsen, VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006;43:971–978.Google Scholar
15. European Antimicrobial Resistance Surveillance System. Annual report 2004. Available at:http://www.rivm.nl/earss. Accessed September 27, 2007.Google Scholar
16.Lucet, JC, Decre, D, Fichelle, A, et al. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing Enterobacteriaceae in a university hospital. Clin Infect Dis 1999;29:1411–1418.Google Scholar
17.Lucet, JC, Grenet, K, Armand-Lefevre, L, et al. High prevalence of carriage of methicillin-resistant Staphylococcus aureus at hospital admission in elderly patients: implications for infection control strategies. Infect Control Hosp Epidemiol 2005;26:121–126.CrossRefGoogle ScholarPubMed
18.Scanvic, A, Denic, L, Gaillon, S, Giry, P, Andremont, A, Lucet, JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001;32:1393–1398.Google Scholar
19.McCabe, WR, Jackson, GG. Gram-negative bacteremia. II. Etiology and ecology. Ann Intern Med 1962;110:847–855.Google Scholar
20.Knaus, WA, Zimmerman, JE, Wagner, DP, Draper, EA, Lawrence, DE. APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 1981;9:591–597.Google Scholar
21.Charlson, ME, Sax, FL, MacKenzie, CR, Fields, SD, Braham, RL, Douglas, RG Jr. Assessing illness severity: does clinical judgment work? J Chronic Dis 1986;39:439–452.Google Scholar
22.Fierobe, L, Lucet, JC, Decre, D, et al. An outbreak of imipenem-resistant Acinetobacter baumannii in critically ill surgical patients. Infect Control Hosp Epidemiol 2001;22:35–40.Google Scholar
23.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.Google Scholar
24.Harris, AD, McGregor, JC, Furuno, JP. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis 2006;43:S57–61.CrossRefGoogle ScholarPubMed
25.Weber, SG, Gold, HS, Hooper, DC, Karchmer, AW, Carmeli, Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003;9:1415–1422.Google Scholar
26.Charbonneau, P, Parienti, JJ, Thibon, P, et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis 2006;42:778–784.CrossRefGoogle ScholarPubMed
27.Rodriguez-Bano, J, Navarro, MD, Romero, L, et al. Clinical and molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Infect Dis 2006;42:37–45.Google Scholar
28.Rodriguez-Bano, J, Paterson, DL. A change in the epidemiology of infections due to extended-spectrum β-lactamase-producing organisms. Clin Infect Dis 2006;42:935–937.Google ScholarPubMed
29.Ayats, J, Corbella, X, Ardanuy, C, et al. Epidemiological significance of cutaneous, pharyngeal, and digestive tract colonization by multiresistant Acinetobacter baumannii in ICU patients. J Hosp Infect 1997;37:287–295.Google Scholar